Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Seattle Genetics Inc (NQ: SGEN )

192.34 USD -2.51 (-1.29%)
Official Closing Price Updated: 4:54 PM EDT, Oct 29, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 772,859
Open 194.96
Bid (Size) 178.50 (1)
Ask (Size) 182.50 (3)
Prev. Close 194.85
Today's Range 189.02 - 196.10
52wk Range 90.57 - 213.94
Shares Outstanding 158,224,428
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Seagen Reports Third Quarter 2020 Financial Results
Seagen Inc. (Nasdaq:SGEN) today reported financial results for the third quarter and nine months ended September 30, 2020. The Company also highlighted ADCETRIS® (brentuximab vedotin), PADCEV®... 
From Business Wire News Releases
Astellas and Seagen Announce Positive Topline Results from Second Cohort of Patients in Phase 2 Pivotal Trial of PADCEV® (enfortumab vedotin-ejfv) in Advanced Urothelial Cancer
- Durable Responses Observed in Patients Who Had Previously Received Immunotherapy but Were Ineligible for Cisplatin in Locally Advanced or Metastatic Setting - 
From PR Newswire

Performance

YTD
+71.11%
+71.11%
1 Month
+0.96%
+0.96%
3 Month
+14.20%
+14.20%
6 Month
+39.30%
+39.30%
1 Year
+82.78%
+82.78%

More News

Read More
Seagen Announces Closing of $1.0 Billion Stock Sale to Merck
From Business Wire News Releases
Seagen to Host Conference Call and Webcast Discussion of Third Quarter 2020 Financial Results on October 29, 2020
From Business Wire News Releases
Seagen and Astellas Announce Positive Topline Results from Second Cohort of Patients in Phase 2 Pivotal Trial of PADCEV® (enfortumab vedotin-ejfv) in Advanced Urothelial Cancer
From Business Wire News Releases
Seattle Genetics, Inc. Announces Corporate Name Change to Seagen Inc.
From Business Wire News Releases
Noteworthy Thursday Option Activity: DNLI, TDOC, SGEN
Tags Stocks
From Market News Video
'Halftime Report Traders' Share Their Thoughts On Target, Johnson & Johnson And More
Tags SGEN CNBC JNJ
From Benzinga
5 Big Pharma/Biotech Stocks Set to Trump Q3 Earnings Estimates
Tags Stocks / Equities
From Blogs - TalkMarkets
'Fast Money Halftime Report' Picks For October 5
Tags Market News GBX STZ
From Benzinga
Why Seattle Genetics Stock Jumped 24% in September
Tags MRK Market News SGEN
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.